2001 -2002 Associate Director, Medical Marketing, US AVONEX @
1999 -2001 Marketing Manager, US AVONEX @
1997 -1999 Global Product Manager @ Sanofi Genzyme
1996 -1997 Cardiovascular Product Manager @
1995 -1996 National Sales Trainer, Program Development Unit @
1993 -1995 Sales Representative @
Alex Waldron Education
Boston University
Bachelor's degree (Political Science and Government)
Boston University
BA (International Business and Economics)
Alex Waldron Skills
Board Development
Board of Directors
Fundraising
Operations Management
Cross-functional Team Leadership
Strategy
Pharmaceutical Industry
Biotechnology
Commercialization
Global Marketing
Neurology
Life Sciences
Product Launch
Marketing Strategy
Business Development
Business Strategy
Pharmaceutical Sales
Drug Development
Marketing
Clinical Development
Portfolio Optimization
Specialty Pharmaceutical
Strategic Partnerships
Cardiology
Training and Development
Sales
Gastroenterology
Portfolio Management
Sales Operations
Collaboration Management
Geographic Expansion
Immunology
Competitive Analysis
Hematology
Hospital Sales
Anesthesiology
Business Planning
Lifesciences
Sales Effectiveness
Pharmaceuticals
Product Strategy
Cross Functional Team Leadership
New Business Development
Asia Pacific
Product Life Cycle Management
Diabetes
Rheumatology
Market Access
Therapeutic Areas
Rare Diseases
Portfolio Strategy
Brand Architecture
Operational Marketing
Alex Waldron Summary
Alex Waldron, based in Boston, MA, US, is currently a Chief Executive Officer at Neutargeton Therapeutics. Alex Waldron brings experience from previous roles at Yale Ventures, Embr Labs, Wellinks and Pear Therapeutics. Alex Waldron holds a Bachelor's degree in Political Science and Government @ Boston University. With a robust skill set that includes Board Development, Board of Directors, Fundraising, Operations Management, Cross-functional Team Leadership and more. Alex Waldron has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Alex Waldron?
Find contact details for 700 million professionals.